José Antonio Allué

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Shorena Janelidze, Charlotte E. Teunissen, Henrik Zetterberg et al. · JAMA Neurology · 2021 · 474 citations · Full text

Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau

Shorena Janelidze, Sebastian Palmqvist, Antoine Leuzy et al. · Alzheimer s & Dementia · 2021 · 193 citations · Full text

Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations

Nicholas Cullen, Antoine Leuzy, Sebastian Palmqvist et al. · Nature Aging · 2020 · 189 citations

Alzheimer's Disease, Plasma Biomarker Combinations, Medicine +10

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline

María Pascual‐Lucas, José Antonio Allué, Leticia Sarasa et al. · Alzheimer s Research & Therapy · 2023 · 38 citations · Full text

Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort

Hyemin Jang, Ji Sun Kim, Hye Joo Lee et al. · Alzheimer s Research & Therapy · 2021 · 33 citations · Full text